Who owns ANRO?
Institutional ownership of Alto Neuroscience Inc. from Form 13F, Q2 2026
114 institutional managers reported holding Alto Neuroscience Inc. (ANRO) in Form 13F filings for Q2 2026, with 29,473,067 shares worth $778M. The largest reported holder was Alpha Wave Global, LP. Managers that filed both quarters added a net 2,642,468 shares (+9.8%). 27 opened new positions and 22 sold out.
- Funds holding
- 114
- Value held
- $778M
- New / sold out
- 27 / 22
- Net shares, same filers
- +9.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ANRO
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Alpha Wave Global, LP | $97.8M | 12.6% | 3,707,757 | Unchanged |
| Commodore Capital LP | $71.9M | 9.2% | 2,723,196 | Unchanged |
| BlackRock, Inc. | $56.0M | 7.2% | 2,121,009 | Added |
| Perceptive Advisors LLC | $42.5M | 5.5% | 1,609,893 | Trimmed |
| Adage Capital Partners GP, L.l.c. | $42.2M | 5.4% | 1,600,000 | Added |
| Vanguard Capital Management LLC | $36.7M | 4.7% | 1,389,477 | Added |
| Spruce Street Capital LP | $35.7M | 4.6% | 1,353,047 | Added |
| Vivo Capital, LLC | $31.9M | 4.1% | 1,208,858 | Added |
| Franklin Resources Inc | $26.7M | 3.4% | 1,013,307 | Trimmed |
| Armistice Capital, LLC | $22.8M | 2.9% | 864,000 | Trimmed |
| Affinity Asset Advisors, LLC | $22.4M | 2.9% | 850,000 | Added |
| Vestal Point Capital, LP | $20.7M | 2.7% | 785,000 | Trimmed |
| State Street Corp | $18.1M | 2.3% | 685,945 | Added |
| Geode Capital Management, LLC | $17.9M | 2.3% | 678,199 | Added |
| 72 Investment Holdings, LLC | $17.6M | 2.3% | 667,778 | Unchanged |
| Northern Trust Corp | $16.7M | 2.1% | 632,701 | Added |
| Millennium Management LLC | $14.7M | 1.9% | 558,320 | Trimmed |
| Point72 Asset Management, L.P. | $13.3M | 1.7% | 502,950 | Unchanged |
| Integral Health Asset Management, LLC | $13.2M | 1.7% | 500,000 | Unchanged |
| Venrock Adviser, LLC | $13.2M | 1.7% | 500,000 | Unchanged |
| Driehaus Capital Management LLC | $12.9M | 1.7% | 487,576 | Added |
| Parkman Healthcare Partners LLC | $11.3M | 1.5% | 429,035 | New |
| Ikarian Capital, LLC | $10.7M | 1.4% | 407,338 | Trimmed |
| Price T Rowe Associates Inc | $9.5M | 1.2% | 358,279 | Trimmed |
| Orbimed Advisors LLC | $6.8M | 0.9% | 257,852 | Added |
Share of 13F holdings is each fund's shares as a share of the 29,473,067 ANRO shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$38.4M
- Adage Capital Partners GP, L.l.c. Added+$32.1M
- State Street Corp Added+$12.8M
- Parkman Healthcare Partners LLC New+$11.3M
- Geode Capital Management, LLC Added+$10.2M
- Affinity Asset Advisors, LLC Added+$9.2M
- Schonfeld Strategic Advisors LLC New+$6.8M
- Vanguard Capital Management LLC Added+$4.8M
- Vanguard Portfolio Management LLC New+$4.8M
- Ameriprise Financial Inc Added+$4.7M
Biggest sellers in Q2 2026
- Vestal Point Capital, LP Trimmed-$33.8M
- Perceptive Advisors LLC Trimmed-$10.6M
- Jennison Associates LLC Sold out-$8.7M
- Millennium Management LLC Trimmed-$7.0M
- Susquehanna International Group, LLP Trimmed-$6.1M
- Qube Research & Technologies Ltd Sold out-$4.7M
- Alkeon Capital Management LLC Trimmed-$3.3M
- Ikarian Capital, LLC Trimmed-$2.8M
- AWM Investment Company, Inc. Trimmed-$2.4M
- Franklin Resources Inc Trimmed-$2.3M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $171M and sold $97.8M; 39 added and 26 trimmed.
Schedule 13D and 13G filings on ANRO
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-07-20EcoR1 Capital, LLC SCHEDULE 13G filed by Alto Neuroscience Inc.Schedule 13G
- 2026-02-17Vestal Point Capital, LP SCHEDULE 13G filed by Alto Neuroscience Inc.Schedule 13G
- 2025-10-27Commodore Capital LP SCHEDULE 13G filed by Alto Neuroscience Inc.Schedule 13G
- 2025-10-10PERCEPTIVE ADVISORS LLC SCHEDULE 13G filed by Alto Neuroscience Inc.Schedule 13G
- 2025-05-15K2 HealthVentures Equity Trust LLC SCHEDULE 13G filed by Alto Neuroscience Inc.Schedule 13G
- 2025-05-15ARMISTICE CAPITAL, LLC SCHEDULE 13G filed by Alto Neuroscience Inc.Schedule 13G
Questions about ANRO ownership
- Who owns ANRO stock?
- 114 institutional investment managers reported ANRO positions in their Form 13F filings for Q2 2026, holding 29,473,067 shares worth $778M in total. Alpha Wave Global, LP reported the largest position.
- Are funds buying or selling ANRO?
- In Q2 2026, 27 managers opened new ANRO positions, 39 added, 26 trimmed and 22 sold out. Managers that filed in both quarters added a net 2,642,468 shares.
- How current is this ANRO institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ANRO by CUSIP. Options are left out. ANRO news and filings · ANRO insider trades · Top funds